Prevalence of ARVI, influenza, and COVID-19 pathogens in individuals without symptoms of respiratory infection
Introduction. SARS-CoV-2 can be transmitted by infected people without or with mild symptoms of acute respira-tory infection (ARI). Monitoring based on nucleic acid amplification techniques is used to measure the prevalence of ARI pathogens and to assess the effectiveness of preventive measures.The...
Main Authors: | S. B. Yatsyshina, M. V. Mamoshina, M. A. Elkina, G. V. Sharukho, Yu. I. Raspopova, А. Ya. Folmer, K. A. Agapov, I. M. Vladimirov, O. V. Zubareva, I. S. Novikova, O. B. Bondareva, V. A. Gil, D. N. Kozlovskikh, S. V. Romanov, O. V. Dikonskaya, A. V. Ponomareva, I. V. Chistyakova, N. I. Kochneva, A. I. Yurovskikh, E. P. Kadnikova, A. S. Kilyachina, S. V. Luchinina, R. R. Kosareva, G. G. Chirkova, N. N. Valeullina, L. A. Lebedeva, T. N. Detkovskaya, E. I. Abbasova, O. B. Romanova, E. V. Pyatyrova, V. G. Akimkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2021-09-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.elpub.ru/jour/article/view/1089 |
Similar Items
-
Peculiarities of Seroprovalence to SARS-CoV-2 in the Population of the Middle and Southern Urals in the Early Period of the COVID-19 Pandemic
by: A. Yu. Popova, et al.
Published: (2021-07-01) -
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)
by: N Yu Pshenichnaya, et al.
Published: (2019-03-01) -
ARVI antiviral therapy in children in modern clinical practice
by: E. A. Dondurey, et al.
Published: (2019-02-01) -
Treatment of ARVI and influenza in patients with arterial hypertension
by: E V Silina, et al.
Published: (2019-09-01) -
Treatment of cough in children with ARVI
by: E. M. Ovsyannikova, et al.
Published: (2015-12-01)